KEGG   Theropithecus gelada (gelada): 112606473
Entry
112606473         CDS       T08041                                 
Symbol
BAD
Name
(RefSeq) bcl2-associated agonist of cell death isoform X1
  KO
K02158  Bcl-2-antagonist of cell death
Organism
tge  Theropithecus gelada (gelada)
Pathway
tge01521  EGFR tyrosine kinase inhibitor resistance
tge01522  Endocrine resistance
tge01524  Platinum drug resistance
tge04012  ErbB signaling pathway
tge04014  Ras signaling pathway
tge04022  cGMP-PKG signaling pathway
tge04024  cAMP signaling pathway
tge04062  Chemokine signaling pathway
tge04140  Autophagy - animal
tge04151  PI3K-Akt signaling pathway
tge04210  Apoptosis
tge04370  VEGF signaling pathway
tge04510  Focal adhesion
tge04722  Neurotrophin signaling pathway
tge04910  Insulin signaling pathway
tge04919  Thyroid hormone signaling pathway
tge05010  Alzheimer disease
tge05014  Amyotrophic lateral sclerosis
tge05020  Prion disease
tge05022  Pathways of neurodegeneration - multiple diseases
tge05145  Toxoplasmosis
tge05152  Tuberculosis
tge05160  Hepatitis C
tge05161  Hepatitis B
tge05162  Measles
tge05165  Human papillomavirus infection
tge05168  Herpes simplex virus 1 infection
tge05170  Human immunodeficiency virus 1 infection
tge05200  Pathways in cancer
tge05203  Viral carcinogenesis
tge05207  Chemical carcinogenesis - receptor activation
tge05208  Chemical carcinogenesis - reactive oxygen species
tge05210  Colorectal cancer
tge05211  Renal cell carcinoma
tge05212  Pancreatic cancer
tge05213  Endometrial cancer
tge05215  Prostate cancer
tge05218  Melanoma
tge05220  Chronic myeloid leukemia
tge05221  Acute myeloid leukemia
tge05223  Non-small cell lung cancer
tge05225  Hepatocellular carcinoma
tge05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:tge00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04014 Ras signaling pathway
    112606473 (BAD)
   04024 cAMP signaling pathway
    112606473 (BAD)
   04022 cGMP-PKG signaling pathway
    112606473 (BAD)
   04151 PI3K-Akt signaling pathway
    112606473 (BAD)
 09140 Cellular Processes
  09141 Transport and catabolism
   04140 Autophagy - animal
    112606473 (BAD)
 09150 Organismal Systems
  09151 Immune system
   04062 Chemokine signaling pathway
    112606473 (BAD)
  09152 Endocrine system
   04919 Thyroid hormone signaling pathway
    112606473 (BAD)
  09156 Nervous system
   04722 Neurotrophin signaling pathway
    112606473 (BAD)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    112606473 (BAD)
   05207 Chemical carcinogenesis - receptor activation
    112606473 (BAD)
   05208 Chemical carcinogenesis - reactive oxygen species
    112606473 (BAD)
   05203 Viral carcinogenesis
    112606473 (BAD)
  09162 Cancer: specific types
   05210 Colorectal cancer
    112606473 (BAD)
   05212 Pancreatic cancer
    112606473 (BAD)
   05225 Hepatocellular carcinoma
    112606473 (BAD)
   05221 Acute myeloid leukemia
    112606473 (BAD)
   05220 Chronic myeloid leukemia
    112606473 (BAD)
   05218 Melanoma
    112606473 (BAD)
   05211 Renal cell carcinoma
    112606473 (BAD)
   05215 Prostate cancer
    112606473 (BAD)
   05213 Endometrial cancer
    112606473 (BAD)
   05223 Non-small cell lung cancer
    112606473 (BAD)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    112606473 (BAD)
   05161 Hepatitis B
    112606473 (BAD)
   05160 Hepatitis C
    112606473 (BAD)
   05162 Measles
    112606473 (BAD)
   05165 Human papillomavirus infection
    112606473 (BAD)
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    112606473 (BAD)
  09174 Infectious disease: parasitic
   05145 Toxoplasmosis
    112606473 (BAD)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    112606473 (BAD)
   05014 Amyotrophic lateral sclerosis
    112606473 (BAD)
   05020 Prion disease
    112606473 (BAD)
   05022 Pathways of neurodegeneration - multiple diseases
    112606473 (BAD)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    112606473 (BAD)
  09176 Drug resistance: antineoplastic
   01521 EGFR tyrosine kinase inhibitor resistance
    112606473 (BAD)
   01524 Platinum drug resistance
    112606473 (BAD)
   01522 Endocrine resistance
    112606473 (BAD)
SSDB
Motif
Pfam: Bcl-2_BAD Bclx_interact
Other DBs
NCBI-GeneID: 112606473
NCBI-ProteinID: XP_025212801
Ensembl: ENSTGEG00000012477
LinkDB
Position
14:10330041..10344773
AA seq 221 aa
MFQIPEFEPSEQEDSSSAERGLGPSPAGDKPSDSGKHHRQAPGLLWDASHQQEQPTSSSH
HGGAGAVETRSRHSSYPAGTEEDEGMEEEPSPFRGRSRSAPPNLWAAQRYGRELRRMSDE
FVDSFKVRTSSPEERGHSDADAAKLQLDASLPVLVGSELGQGKLRPLPVTFAPRPETPPA
LTVLVGHLGYGRKCFPQALCKRGSVLPLSVGGLTQIPFRCM
NT seq 666 nt   +upstreamnt  +downstreamnt
atgttccagatcccagagtttgagcctagtgagcaggaagactccagctctgcagagagg
ggcctgggccccagccccgcgggggacaagccctcagactccggcaagcatcatcgccag
gccccaggcctcctgtgggacgccagtcaccagcaggagcagccaaccagcagcagccat
catggaggcgctggggctgtggagacgcggagtcgccacagctcctaccccgcggggacg
gaggaggacgaagggatggaggaggagcccagcccctttcggggccgctcgcgctccgcg
ccccccaacctctgggcagcacagcgttatggccgcgagctccggaggatgagtgacgag
tttgtggactcctttaaggtgaggacttcctcgcccgaagagcgcgggcacagcgacgca
gatgcggcaaagctccagctggacgcgagtcttccagtcctggtgggatcggaacttggg
caggggaagctccgccccctcccagtgaccttcgctccacgccccgaaactccacccgct
ctcactgtcctggtcggccatcttggatatgggcggaagtgcttccctcaggccttatgc
aaaagaggatccgtgctccctctttcggtgggagggctgacccagattcccttccggtgc
atgtga

DBGET integrated database retrieval system